China Reform Health Management and Services Group Co., Ltd. (SHE:000503)
6.40
+0.10 (1.59%)
Jul 10, 2026, 3:04 PM CST
SHE:000503 Revenue
China Reform Health Management and Services Group had revenue of 50.52M CNY in the quarter ending March 31, 2026, with 0.10% growth. This brings the company's revenue in the last twelve months to 350.50M, down -2.49% year-over-year. In the year 2025, China Reform Health Management and Services Group had annual revenue of 350.44M, down -1.81%.
Revenue (ttm)
350.50M
Revenue Growth
-2.49%
P/S Ratio
17.88
Revenue / Employee
281.75K
Employees
1,244
Market Cap
6.27B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 350.44M | -6.45M | -1.81% |
| Dec 31, 2024 | 356.90M | 26.77M | 8.11% |
| Dec 31, 2023 | 330.13M | 19.05M | 6.12% |
| Jan 1, 2023 | 311.08M | 58.56M | 23.19% |
| Jan 1, 2022 | 252.52M | 45.14M | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 46.20B |
| Shenzhen Mindray Bio-Medical Electronics | 33.40B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 32.56B |
| China Animal Husbandry Industry | 6.45B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Cisen Pharmaceutical | 3.37B |
| Guizhou Bailing Group Pharmaceutical | 2.93B |
| Sichuan Biokin Pharmaceutical | 2.55B |